Fry Hannah is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Profile
Hannah Fry is a corporate insider who serves as Vice President and Controller for Protara Therapeutics, Inc. as indicated by the SEC filing dated 2026-01-21 with CIK 0001938146. The filing shows no equity purchases or sales by her, reflecting no disclosed insider trading activity in that filing; Protara Therapeutics is a clinical-stage biotech focused on cancer and rare diseases, including the TARA-002 program and IV choline chloride therapies.
Role
Insider
Notability
35/100
Board memberships
Protara Therapeutics, Inc.
Awards & honors
Oversees financial reporting and internal controls as VP, Controller
Facilitates SEC filings and compliance updates for Protara Therapeutics
Hannah Fry is a corporate insider who serves as Vice President and Controller for Protara Therapeutics, Inc. as indicated by the SEC filing dated 2026-01-21 with CIK 0001938146. The filing shows no equity purchases or sales by her, reflecting no disclosed insider trading activity in that filing; Protara Therapeutics is a clinical-stage biotech focused on cancer and rare disease…
Where can I see all of Fry Hannah's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
